Ruggie Capital Group’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-43
Closed -$7K 312
2019
Q2
$7K Buy
+43
New +$5.95K 0.01% 138
2019
Q1
Sell
-395
Closed -$53K 511
2018
Q4
$53K Buy
+395
New +$64.8K 0.02% 167
2018
Q3
Sell
-25
Closed -$4K 341
2018
Q2
$4K Buy
+25
New +$4.01K ﹤0.01% 286
2018
Q1
Sell
-200
Closed -$33K 337
2017
Q4
$33K Hold
200
0.02% 168
2017
Q3
$41K Buy
+200
New +$46.5K 0.03% 137
2015
Q2
Sell
-28
Closed -$8K 398
2015
Q1
$8K Buy
+28
New +$7.98K 0.01% 151

Other funds holding AGN

Ruggie Capital Group's AGN Position: Q3 2019 in Review

Ruggie Capital Group sold out of Allergan plc (AGN) in Q3 2019, closing a stake of 43 shares — an estimated $7K sold.

Ruggie Capital Group first reported a position in AGN in Q1 2015 and held it in 6 quarters. The position peaked at $53K in Q4 2018. 921 funds tracked by Wall St. Rank hold AGN as of Q3 2019.

  • Ruggie Capital Group reported no remaining Allergan plc position as of Q3 2019 after selling out during the quarter.
  • Ruggie Capital Group sold 43 Allergan plc shares in Q3 2019, an estimated $7K.
  • Ruggie Capital Group first reported a position in Allergan plc in Q1 2015 and held it in 6 quarters.
  • Ruggie Capital Group's Allergan plc position peaked at $53K in Q4 2018.
  • 921 funds tracked by Wall St. Rank held Allergan plc as of Q3 2019.

Based on Ruggie Capital Group's 13F filing for Q3 2019, filed 6 Nov 2019.